Literature DB >> 31296936

Anaemia and iron deficiency in pregnancy and adverse perinatal outcomes in Southern India.

Julia L Finkelstein1,2, Anura V Kurpad3,4, Beena Bose3, Tinku Thomas3, Krishnamachari Srinivasan4, Christopher Duggan5,6.   

Abstract

BACKGROUND/
OBJECTIVES: We examined the prevalence of anaemia, iron deficiency, and inflammation during pregnancy and their associations with adverse pregnancy and infant outcomes in India. SUBJECTS/
METHODS: Three hundred and sixty-six women participating in a randomised trial of vitamin B12 supplementation were monitored to assess haemoglobin (Hb), serum ferritin (SF), hepcidin, C-reactive protein (CRP), and alpha-1-acid glycoprotein (AGP) during pregnancy. Women received vitamin B12 supplementation (50 µg per day) or placebo daily; all women received daily prenatal iron-folic acid supplementation. Binomial and linear regression models were used to examine the associations of maternal iron biomarkers with pregnancy and infant outcomes.
RESULTS: Thirty percent of women were anaemic (Hb < 11.0 g/dl), 48% were iron deficient (SF < 15.0 µg/l), and 23% had iron deficiency anaemia at their first prenatal visit. The prevalence of inflammation (CRP > 5.0 mg/l: 17%; AGP > 1.0 g/l: 11%) and anaemia of inflammation (Hb < 11.0 g/dl, SF > 15.0 µg/l, plus CRP > 5.0 mg/l or AGP > 1.0 g/l: 2%) were low. Infants born to anaemic women had a twofold higher risk of low birth weight (<2500 g; risk ratio [RR]: 2.15, 95%CI: 1.20-3.84, p = 0.01), preterm delivery (RR: 2.67 (1.43-5.00); p = 0.002), underweight (WAZ < -2; RR: 2.20, 95%CI: 1.16-4.15, p = 0.02), and lower MUAC (β(SE): -0.94 (0.45)cm, p = 0.03). Similarly, maternal Hb concentrations predicted higher infant birth weight (p = 0.02) and greater gestational age at delivery (β(SE): 0.28 (0.08) weeks, p = 0.001), lower risk of preterm delivery (<37 weeks; RR: 0.76, 95%CI: 0.66-86, p < 0.0001); and higher infant MUAC (β(SE): 0.36 (0.13) cm, p = 0.006). Maternal SF concentrations were associated with greater birth length (β(SE): 0.44 (0.20) cm, p < 0.03). Findings were similar after adjusting SF concentrations for inflammation. IDA was associated with higher risk of low birth weight (RR: 1.99 (1.08-3.68); p = 0.03) and preterm birth (RR: 3.46 (1.81-6.61); p = 0.0002); and lower birth weight (p = 0.02), gestational age at birth (p = 0.0002), and infant WAZ scores (p = 0.02).
CONCLUSIONS: The prevalence of anaemia and iron deficiency was high early in pregnancy and associated with increased risk of adverse pregnancy and infant outcomes. A comprehensive approach to prevent anaemia is needed in women of reproductive age, to enhance haematological status and improve maternal and child health outcomes.

Entities:  

Mesh:

Year:  2019        PMID: 31296936     DOI: 10.1038/s41430-019-0464-3

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  2 in total

Review 1.  Prevalence & consequences of anaemia in pregnancy.

Authors:  K Kalaivani
Journal:  Indian J Med Res       Date:  2009-11       Impact factor: 2.375

Review 2.  Adjusting ferritin concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project.

Authors:  Sorrel Ml Namaste; Fabian Rohner; Jin Huang; Nivedita L Bhushan; Rafael Flores-Ayala; Roland Kupka; Zuguo Mei; Rahul Rawat; Anne M Williams; Daniel J Raiten; Christine A Northrop-Clewes; Parminder S Suchdev
Journal:  Am J Clin Nutr       Date:  2017-06-14       Impact factor: 7.045

  2 in total
  6 in total

1.  Anemia and adverse outcomes in pregnancy: subgroup analysis of the CLIP cluster-randomized trial in India.

Authors:  Jeffrey N Bone; Mrutyunjaya Bellad; Shivaprasad Goudar; Ashalata Mallapur; Umesh Charantimath; Umesh Ramadurg; Geetanjali Katageri; Maria Lesperance; Mai-Lei Woo Kinshella; Raiya Suleman; Marianne Vidler; Sumedha Sharma; Richard Derman; Laura A Magee; Peter von Dadelszen
Journal:  BMC Pregnancy Childbirth       Date:  2022-05-13       Impact factor: 3.105

2.  Adverse effects of iron deficiency anemia on pregnancy outcome and offspring development and intervention of three iron supplements.

Authors:  Qi Zhang; Xiao-Min Lu; Min Zhang; Chen-Ying Yang; Si-Yuan Lv; Shi-Fen Li; Cai-Yun Zhong; Shan-Shan Geng
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

3.  Prevalence of iron deficiency in pregnant women: A prospective cross-sectional Austrian study.

Authors:  Harald Zeisler; Wolf Dietrich; Florian Heinzl; Philipp Klaritsch; Victoria Humpel; Manfred Moertl; Christian Obruca; Friedrich Wimazal; Angela Ramoni; Johanna Tiechl; Elisabeth Wentzel-Schwarz
Journal:  Food Sci Nutr       Date:  2021-10-16       Impact factor: 2.863

4.  Diagnosis and Therapy of Iron Deficiency Anemia During Pregnancy: Recommendation of the Austrian Society for Gynecology and Obstetrics (OEGGG).

Authors:  Thorsten Fischer; Hanns Helmer; Philipp Klaritsch; Claudius Fazelnia; Gerhard Bogner; Katharina M Hillerer; Christoph Wohlmuth; Heidi Jaksch-Bogensperger
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-04-05       Impact factor: 2.915

5.  Association Between Serum Ferritin Concentration and Risk of Adverse Maternal and Fetal Pregnancy Outcomes: A Retrospective Cohort Study.

Authors:  Lanyao Yang; Lanlan Wu; Yao Liu; Hengying Chen; Yuanhuan Wei; Ruifang Sun; Siwen Shen; Bowen Zhan; Jianjun Yang; Guifang Deng
Journal:  Diabetes Metab Syndr Obes       Date:  2022-09-19       Impact factor: 3.249

6.  High burden of anemia among pregnant women in Tanzania: a call to address its determinants.

Authors:  Bruno F Sunguya; Yue Ge; Linda Mlunde; Rose Mpembeni; Germana Leyna; Jiayan Huang
Journal:  Nutr J       Date:  2021-07-08       Impact factor: 3.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.